Assessment of health-related quality of life and health utilities in Australian patients with cirrhosis.
chronic liver disease
health utilities
quality of life
short form‐36
Journal
JGH open : an open access journal of gastroenterology and hepatology
ISSN: 2397-9070
Titre abrégé: JGH Open
Pays: Australia
ID NLM: 101730833
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
17
09
2020
accepted:
11
11
2020
entrez:
25
1
2021
pubmed:
26
1
2021
medline:
26
1
2021
Statut:
epublish
Résumé
Health-related quality-of-life measurements are important to understand lived experiences of patients who have cirrhosis. These measures also inform economic evaluations by modelling quality-adjusted life years (QALYs). We aimed to describe health-related quality of life, specifically multiattribute utility (scale anchors of death = 0.00 and full health = 1.00), across various stages and etiologies of cirrhosis. Face-to-face interviews were used to collect Short Form 36 (SF-36) questionnaire responses from CirCare study participants with cirrhosis (June 2017 to December 2018). The severity of cirrhosis was assessed using the Child-Pugh score classified as class A (5-6 points), B (7-9), or C (10-15) and by the absence ("compensated") Patients ( Persons with more advanced cirrhosis report greater life impacts. Estimates from this study are suitable for informing economic evaluations, particularly cost-utility modelling, which captures the benefits of effective prevention, surveillance, and treatments on both the quality and quantity of patients' lives.
Sections du résumé
BACKGROUND AND AIM
OBJECTIVE
Health-related quality-of-life measurements are important to understand lived experiences of patients who have cirrhosis. These measures also inform economic evaluations by modelling quality-adjusted life years (QALYs). We aimed to describe health-related quality of life, specifically multiattribute utility (scale anchors of death = 0.00 and full health = 1.00), across various stages and etiologies of cirrhosis.
METHODS
METHODS
Face-to-face interviews were used to collect Short Form 36 (SF-36) questionnaire responses from CirCare study participants with cirrhosis (June 2017 to December 2018). The severity of cirrhosis was assessed using the Child-Pugh score classified as class A (5-6 points), B (7-9), or C (10-15) and by the absence ("compensated")
RESULTS
RESULTS
Patients (
CONCLUSIONS
CONCLUSIONS
Persons with more advanced cirrhosis report greater life impacts. Estimates from this study are suitable for informing economic evaluations, particularly cost-utility modelling, which captures the benefits of effective prevention, surveillance, and treatments on both the quality and quantity of patients' lives.
Identifiants
pubmed: 33490623
doi: 10.1002/jgh3.12462
pii: JGH312462
pmc: PMC7812472
doi:
Types de publication
Journal Article
Langues
eng
Pagination
133-142Informations de copyright
© 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Health Econ. 2002 Jul;11(5):447-56
pubmed: 12112493
Dig Liver Dis. 2005 Aug;37(8):593-600
pubmed: 15869912
Health Qual Life Outcomes. 2010 Jul 10;8:65
pubmed: 20618978
Risk Manag Healthc Policy. 2016 Jul 05;9:143-56
pubmed: 27462182
Qual Life Res. 1999 May;8(3):209-24
pubmed: 10472152
Am J Gastroenterol. 2001 Feb;96(2):579-83
pubmed: 11232711
Qual Life Res. 2016 Oct;25(10):2579-2592
pubmed: 27048497
EClinicalMedicine. 2019 Jun 13;11:44-53
pubmed: 31317132
Neth J Med. 2007 Jul-Aug;65(7):227-34
pubmed: 17656809
Dig Dis Sci. 2004 Mar;49(3):453-8
pubmed: 15139497
Gastroenterol Hepatol (N Y). 2011 Oct;7(10):661-71
pubmed: 22298959
Medicina (Kaunas). 2015;51(4):201-8
pubmed: 26424183
Patient Prefer Adherence. 2020 Mar 18;14:599-611
pubmed: 32256051
Med Care. 2008 Nov;46(11):1140-8
pubmed: 18953224
Health Econ. 2004 Sep;13(9):873-84
pubmed: 15362179
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S383-412
pubmed: 22588759
Appl Health Econ Health Policy. 2015 Jun;13(3):303-9
pubmed: 25288052
Clin Rehabil. 2010 Nov;24(11):1036-44
pubmed: 20702509
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Liver Int. 2009 Mar;29(3):449-58
pubmed: 19267865
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Am J Med Qual. 2018 Jul;33(4):359-364
pubmed: 29258323
Hepatology. 2004 Aug;40(2):489-94
pubmed: 15368455
JBI Database System Rev Implement Rep. 2015 Jan;13(1):39-51
pubmed: 26447006
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Arch Phys Med Rehabil. 2007 Apr;88(4):529-36
pubmed: 17398257
Med Care. 2004 Sep;42(9):851-9
pubmed: 15319610
Clin Exp Hepatol. 2018 Dec;4(4):232-239
pubmed: 30603670
Aust N Z J Public Health. 2013 Feb;37(1):17-23
pubmed: 23379801
J Clin Epidemiol. 2015 May;68(5):584-95
pubmed: 25662007